Cancer Gene Therapy Market Size to Grow by $ 2.96 bn through 2021-2025
The cancer gene therapy market is expected to grow by $ 2.96 bn, accelerating at a CAGR of almost 20% during the forecast period. Technavio’s research report traces the growth trajectory of the market and provides a detailed analysis of the prevalent market forces, trends, and drivers which are likely to impact the market in focus. View Free Sample Report
Cancer Gene Therapy Market: Segmentation by Application
This report provides a detailed analysis of the market by Application (Oncolytic virotherapy, Gene transfer, and Gene-induced immunotherapy) and Geography (North America, Europe, Asia, and ROW). This research report will provide insights into the current market share of each segment along with growth projections for the next five years. In addition, the report also offers a detailed impact analysis of various trends, drivers, and challenges which are likely to influence market growth during the forecast period. These insights are expected to equip clients with reliable information based upon which they can design a growth strategy for their business and area of operations.
Cancer Gene Therapy Market: Vendor Analysis
The market is fragmented. The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions. Adaptimmune Therapeutics plc, Advantagene Inc., Amgen Inc., Anchiano Therapeutics Ltd., bluebird bio Inc., GlaxoSmithKline Plc, Merck KGaA, Shanghai Sunway Biotech Co. Ltd., Sibiono GeneTech Co. Ltd. Shenzhen (Sibiono), and ZIOPHARM Oncology Inc. are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their position in the slow-growing segments.
For more insights into this market: Download a Free Sample Report. Our custom reports provide market insights at the global and regional level along with a pipeline analysis of new product launches. It also provides a peek into the latest R&D along with an impact analysis of government regulations.
Technavio has been monitoring the global cancer gene therapy market and it is expected to grow by USD 2.96 billion accelerating at a CAGR of over 20% during the forecast period. The growth trajectory of the market is traced through a detailed analysis of the prevalent market forces, trends, and drivers along with competitive benchmarking. View Free Sample Report
Cancer Gene Therapy Market: Segmentation by Application
During 2020, the oncolytic virotherapy segment accounted for the major share of the Cancer Gene Therapy Market. The oncolytic virotherapy is the primarily preferred treatment. This therapy involves the use of anticancer cells that destroy the cancer cells without harming the normal cells. Residual tumor cells are killed by anti-tumor immune response through this therapy. Hence the market segment will exhibit a fast growth rate during the forecast period.
Cancer Gene Therapy Market: Segmentation by Geography
North America was the largest Cancer Gene Therapy Market in 2020, and the region will offer several growth opportunities to market vendors during the forecast period. 51% of the market’s growth will originate from North America during the forecast period. The US and Canada are the key markets for cancer gene therapy in North America. Market growth in this region will be slower than the growth of the market in Asia and ROW. The huge investment in the R&D activities for the healthcare segment to curb the rising number of cancer-related deaths is one of the prime factors that will facilitate the cancer gene therapy market growth in North America over the forecast period.
Cancer Gene Therapy Market: Vendor Analysis
The market is fragmented. The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions. Adaptimmune Therapeutics plc, Advantagene Inc. and Amgen Inc. are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their position in the slow-growing segments.
Technavio offers custom research reports with detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will help clients keep up with new product launches in direct & indirect COVID-19 related markets. It will also provide insights on upcoming developments along with pipeline analysis of vendor operations and the impact of government regulations.
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19 Download a Free Sample Report
